These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 32998520)
1. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Shokoples BG; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):186-199. PubMed ID: 32998520 [TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy. Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231 [TBL] [Abstract][Full Text] [Related]
3. P2X Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940 [TBL] [Abstract][Full Text] [Related]
4. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation. Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215 [TBL] [Abstract][Full Text] [Related]
5. P2X7 receptor in cardiovascular disease: The heart side. Guerra Martinez C Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550 [TBL] [Abstract][Full Text] [Related]
6. The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases. Chen Z; He L; Li L; Chen L Clin Chim Acta; 2018 Apr; 479():196-207. PubMed ID: 29366837 [TBL] [Abstract][Full Text] [Related]
7. Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. Bhattacharya A; Jones DNC Psychoneuroendocrinology; 2018 Dec; 98():95-100. PubMed ID: 30121550 [TBL] [Abstract][Full Text] [Related]
8. Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis. Li X; Zhang Y; Jin Q; Xia KL; Jiang M; Cui BW; Wu YL; Song SZ; Lian LH; Nan JX Br J Pharmacol; 2018 May; 175(9):1451-1470. PubMed ID: 29338075 [TBL] [Abstract][Full Text] [Related]
9. Purinergic P2X7 Receptor Mediates the Elimination of Trichinella spiralis by Activating NF-κB/NLRP3/IL-1β Pathway in Macrophages. Guan F; Jiang W; Bai Y; Hou X; Jiang C; Zhang C; Jacques ML; Liu W; Lei J Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558327 [TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor and the NLRP3 inflammasome: Partners in crime. Pelegrin P Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010 [TBL] [Abstract][Full Text] [Related]
11. [Advance in the research on P2X7 and inflammatory respiratory diseases]. Cao SH; Yuan SP; Hou Q Yao Xue Xue Bao; 2013 Aug; 48(8):1183-8. PubMed ID: 24187823 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1 Zhou J; Tian G; Quan Y; Li J; Wang X; Wu W; Li M; Liu X Oxid Med Cell Longev; 2020; 2020():7956274. PubMed ID: 32566102 [TBL] [Abstract][Full Text] [Related]
13. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969 [TBL] [Abstract][Full Text] [Related]
14. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages. Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059 [TBL] [Abstract][Full Text] [Related]
15. The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers. Rossi C; Santini E; Chiarugi M; Salvati A; Comassi M; Vitolo E; Madec S; Solini A Eur J Clin Invest; 2014; 44(3):295-302. PubMed ID: 24372548 [TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263 [TBL] [Abstract][Full Text] [Related]
17. Ethanol upregulates the P2X7 purinergic receptor in human macrophages. Le Daré B; Victoni T; Bodin A; Vlach M; Vene E; Loyer P; Lagente V; Gicquel T Fundam Clin Pharmacol; 2019 Feb; 33(1):63-74. PubMed ID: 30447168 [TBL] [Abstract][Full Text] [Related]
18. Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7. Hussen J; Düvel A; Koy M; Schuberth HJ Dev Comp Immunol; 2012 Oct; 38(2):312-20. PubMed ID: 22728096 [TBL] [Abstract][Full Text] [Related]
20. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer. Bae JY; Lee SW; Shin YH; Lee JH; Jahng JW; Park K Oncotarget; 2017 Jul; 8(30):48972-48982. PubMed ID: 28430665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]